Oral Health Group
News

FDA Flags Risk of Dental Issues From Use of Opioid Addiction Drug Buprenorphine

January 13, 2022
by Reuters


The U.S. health regulator on Wednesday warned patients and prescribers about the risk of potential dental problems arising from the use of buprenorphine medicines to treat opioid addiction and pain.

The Food and Drug Administration said the opioid addiction treatment has been reported to cause tooth decay, infection, and, in some cases, total tooth loss in patients with no history of dental issues.

The buprenorphine medicines that are associated with dental problems are tablets dissolved under the tongue and films placed against the inside of the cheek.

View the full story.


See more of the latest dentistry news! 


Print this page

Related


Have your say:

Your email address will not be published. Required fields are marked *

*